An interventional study of Nutritional product in Iron Status, sponsored by Nutricia Research. Recruiting at 1 site in Indonesia. Open to participants aged 12 Months to 36 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-01.
Sponsored by Nutricia Research (part of Danone) · Not applicable, Interventional, and Basic science
Among 17 studies in Anemia with a site in Indonesia — 4 open to participants now, 5 under way, 1 of them phase 3. Anemia · Indonesia.
Among the 17 studies in Anemia with a site in Indonesia, this one is the 4th largest by planned enrollment of the 15 interventional ones, is one of 3 that started in 2026, is one of 7 with no phase, and was the 15th registered.
1,810 studies on the registry are indexed under Anemia; 215 are open to participants now.
This study's planned enrollment of 466 is above the median of 117 across 1,336 interventional studies indexed under Anemia.
Browse Anemia studies →4 of the 17 studies in Anemia with a site in Indonesia are open now, in 11 countries. Each count lists the studies.
Of the 122 Anemia studies recruiting now, 67 (55%) set no upper age limit and 37 (30%) stop at 75 or younger; 34 take children under 18; 23 take healthy volunteers.
This study: 12 Months to 36 Months · all sexes · healthy volunteers too.
The full table on the hub →17 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 3 started in 2026.
Median enrollment 324 across the 15 interventional studies, 145 across the 2 observational. Of the 6 that completed or were terminated, 2 (33%) have results posted.
6 of 17 have an industry lead sponsor. The 10 most frequent:
Nutricia Research is the lead sponsor of 51 studies on the registry; 10 are open to participants now.
Nutricia Research has 1 study filed under Anemia — fewer than ten, so there is no comparison to draw.
3 of the studies in Anemia with a site in Indonesia that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06466785Phase 3Genexine, Inc.A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis | 2027-06 |
| NCT07324135Nutricia ResearchEffect of Young Child Formula on Iron Status in Children 1-3 Years of Age. | 2026-12 |
| NCT07701499Tarumanagara UniversityValidation of Non-Invasive Hemoglobin Measurement Using Optical Method for Anemia Screening Among Adults in Jakarta | 2027-07-30 |
Among the 17 studies in Anemia with a site in Indonesia, from their registry updates:
This study evaluates the effect of young child formula in children 1-3 years of age. Subjects will receive either test or control product. Growth and health data, parent diaries and biological samples will be collected during the study.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The protein in red blood cells that carries oxygen. A low level is anaemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Hemoglobin (Hb)
The protein in red blood cells that carries oxygen. A low level is anaemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Young Child Formula
Other: Nutritional product
Control: cow's milk
Other: Nutritional product
parents will be instructed to provide subjects with 2-3 servings of Study Product per day
Serum ferritin concentration
Time frame: Baseline and 20 weeks post baseline
Daily iron intake
Time frame: Baseline, 10 weeks and 20 weeks post-baseline
Plan to share: No
No publications or documents are linked to this record.
Started Mar 2026 (actual). Primary completion is estimated for Dec 2026, 9 months after the start.
Of 177 interventional studies with no phase under Anemia, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 29. This study's planned 9 months is below that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.